Selank
Synthetic Tuftsin Analog | Anxiolytic & Nootropic Peptide
Selank is a synthetic heptapeptide analog of the naturally occurring immune peptide tuftsin, developed by the Russian Academy of Sciences. This anxiolytic and nootropic peptide has been extensively studied for its ability to reduce anxiety, enhance cognitive function, and modulate immune responses without the side effects associated with traditional benzodiazepines. Selank works through complex interactions with GABAergic, serotonergic, and dopaminergic neurotransmitter systems, offering a unique mechanism for stress reduction and cognitive enhancement.
Daily dose
250-500mcg daily
Frequency
1-2 times daily
Cycle length
2-8 weeks
Storage
2-8°C (refrigerated)
Key benefits
Rapid onset anxiolytic effects, enhanced BDNF expression, improved stress resilience, cognitive enhancement, immune modulation, no tolerance or withdrawal, neuroprotective effects
How it works
Allosteric modulation of GABA-A receptors, serotonin and dopamine system optimization, enkephalin degradation inhibition, IL-6 and cytokine balance regulation, BDNF upregulation in hippocampus
Dosage protocols
Goal
Mild anxiety relief
Dose
250mcg daily · Once daily
Route
SubQ injection
Goal
Moderate anxiety/cognitive enhancement
Dose
250mcg twice daily · Morning and evening
Route
SubQ injection
Goal
Intensive anxiety/stress management
Dose
500mcg daily · Divided doses
Route
SubQ injection
Goal
Cognitive enhancement/nootropic use
Dose
250-350mcg daily · Morning only
Route
SubQ injection
Goal
PTSD/trauma support
Dose
250mcg twice daily · Consistent timing
Route
SubQ injection
Goal
Immune support during stress
Dose
250mcg daily · Once daily for 2-4 weeks
Route
SubQ injection
Research indications
anxiety
cognitive
immune
Administration
Interactions
Safety notes
Start with lowest effective dose (250mcg) to assess individual response
Selank has excellent safety profile with minimal reported side effects
No known tolerance, dependence, or withdrawal issues reported
Can be safely combined with most medications under medical supervision
Store properly refrigerated to maintain peptide stability and potency
Use sterile injection techniques to prevent infection
Consult healthcare provider if taking multiple psychiatric medications
Research studies
GABAergic Neurotransmission Gene Expression (2016)
Rat frontal cortex | 300 μg/kg | Real-time PCR analysis
Demonstrated Selank's modulation of 45 genes involved in neurotransmission, confirming GABAergic mechanism similar to benzodiazepines without negative effects
BDNF Expression Enhancement Study (2010)
Rat hippocampus | 250-500 μg/kg | 24-hour measurement
Found 30% increase in hippocampal BDNF levels, indicating enhanced neuroplasticity and neuroprotective effects
Generalized Anxiety Disorder Clinical Trial (2008)
Human subjects | GAD and neurasthenia | Multi-week treatment
Showed significant anxiolytic and mild nootropic effects lasting up to one week after last dose, improved quality of life without dependence
Memory Consolidation Enhancement (2007)
Rat models | Learning paradigms | Head-to-head with Piracetam
Demonstrated significant activation of learning processes in subjects with initially poor learning ability, effects apparent after first administration